Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2025-03-21 00:00:00 ET · period of report 2024-09-10 · accession 0000950170-25-043291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-21 | 2024-09-10 | PHAT | Parikh Asit | Dir | M - OptEx | $11.72 | +7,500 | 93.0K | +9% | +$87.9K |
| D | 2025-03-21 | 2024-09-10 | PHAT | Parikh Asit | Dir | M - OptEx | $0.00 | -7,500 | 7,500 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-10 | M | A | 7,500 | $11.72 | 93,000 | D | — | — | (F1) The amount in column 5 shows the amount beneficially owned as of the filing date of this report. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-09-10 | M | D | 7,500 | $0.00 | 7,500 | D | $11.72 · 2024-05-25 to 2033-05-24 | 7,500 Common Stock |